📄4mins. A 22-year-old male with diffuse midline glioma began taking 444 mg of Fenbendazole daily after standard treatments failed. Within months, MRI scans showed significant tumor reduction, highlighting Fenbendazole's potential as an alternative brain cancer treatment.
